JP2022505171A5 - - Google Patents
Info
- Publication number
- JP2022505171A5 JP2022505171A5 JP2021521113A JP2021521113A JP2022505171A5 JP 2022505171 A5 JP2022505171 A5 JP 2022505171A5 JP 2021521113 A JP2021521113 A JP 2021521113A JP 2021521113 A JP2021521113 A JP 2021521113A JP 2022505171 A5 JP2022505171 A5 JP 2022505171A5
- Authority
- JP
- Japan
- Prior art keywords
- present
- conjugate
- fap
- linker
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022164850A JP2022191399A (ja) | 2018-10-17 | 2022-10-13 | 線維症における線維芽細胞活性化タンパク質（ｆａｐ）を標的とする撮像法および治療法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862746822P | 2018-10-17 | 2018-10-17 | |
| US62/746,822 | 2018-10-17 | ||
| US201962861028P | 2019-06-13 | 2019-06-13 | |
| US62/861,028 | 2019-06-13 | ||
| PCT/US2019/056257 WO2020081522A1 (en) | 2018-10-17 | 2019-10-15 | Fibroblast activation protein (fap) targeted imaging and therapy in fibrosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022164850A Division JP2022191399A (ja) | 2018-10-17 | 2022-10-13 | 線維症における線維芽細胞活性化タンパク質（ｆａｐ）を標的とする撮像法および治療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505171A JP2022505171A (ja) | 2022-01-14 |
| JP2022505171A5 true JP2022505171A5 (enExample) | 2022-07-19 |
| JP7161044B2 JP7161044B2 (ja) | 2022-10-25 |
Family
ID=70284116
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521113A Expired - Fee Related JP7161044B2 (ja) | 2018-10-17 | 2019-10-15 | 線維症における線維芽細胞活性化タンパク質（ｆａｐ）を標的とする撮像法および治療法 |
| JP2022164850A Withdrawn JP2022191399A (ja) | 2018-10-17 | 2022-10-13 | 線維症における線維芽細胞活性化タンパク質（ｆａｐ）を標的とする撮像法および治療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022164850A Withdrawn JP2022191399A (ja) | 2018-10-17 | 2022-10-13 | 線維症における線維芽細胞活性化タンパク質（ｆａｐ）を標的とする撮像法および治療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US11426472B2 (enExample) |
| EP (1) | EP3867648A4 (enExample) |
| JP (2) | JP7161044B2 (enExample) |
| CN (1) | CN112912731A (enExample) |
| AU (2) | AU2019360944B2 (enExample) |
| CA (1) | CA3116313A1 (enExample) |
| WO (1) | WO2020081522A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7162592B2 (ja) | 2016-12-14 | 2022-10-28 | パーデュー・リサーチ・ファウンデイション | 線維芽細胞活性化タンパク質（ｆａｐ）標的イメージングおよび治療 |
| CN112912731A (zh) * | 2018-10-17 | 2021-06-04 | 普渡研究基金会 | 成纤维细胞活化蛋白(fap)靶向成像和纤维化治疗 |
| WO2021155288A1 (en) * | 2020-01-31 | 2021-08-05 | Philip Stewart Low | Fibroblast activation protein (fap) - targeted antifibrotic therapy |
| MX2022011842A (es) * | 2020-03-24 | 2022-10-20 | Tufts College | Agentes de imagen y radiofarmacos dirigidos a fap, y usos relacionados con los mismos. |
| EP4132921A4 (en) * | 2020-04-09 | 2024-03-27 | Purdue Research Foundation | Pi3 kinase inhibitors and uses thereof |
| EP4147053B1 (en) | 2020-05-07 | 2026-01-28 | Institut Curie | Antxr1 as a biomarker of immunosuppressive fibroblast populations and its use for predicting response to immunotherapy |
| CA3207999A1 (en) * | 2021-02-12 | 2022-08-18 | Samuele CAZZAMALLI | Bivalent fibroblast activation protein ligands for targeted delivery applications |
| JP7868861B2 (ja) * | 2021-03-16 | 2026-06-02 | パーデュー・リサーチ・ファウンデーション | 線維芽細胞活性化タンパク質を標的とする化合物、およびその使用方法 |
| CN114591395B (zh) * | 2021-05-26 | 2023-10-31 | 南方医科大学南方医院 | 一种双配体化合物及其制备方法和应用 |
| CN113880810B (zh) * | 2021-09-24 | 2023-02-28 | 厦门大学 | 一种核素标记的配合物及其制备方法和应用 |
| CN115368342B (zh) * | 2022-08-24 | 2024-01-23 | 西南医科大学附属医院 | 成纤维细胞活性蛋白抑制剂、其放射性核素标记物及制备方法和应用 |
| WO2024102956A1 (en) * | 2022-11-09 | 2024-05-16 | Purdue Research Foundation | Keto-amide-based fibroblast activation protein-targeted ligand linked to an imaging or therapeutic agent, compositions and methods of use |
| CN118619941A (zh) * | 2023-03-03 | 2024-09-10 | 晶核生物医药科技(南京)有限公司 | 一种含氮杂环类化合物及其制备方法与用途 |
| AU2024334645A1 (en) | 2023-08-31 | 2026-02-26 | Stichting Radboud Universitair Medisch Centrum | Endometriosis tracer |
| WO2025102002A1 (en) * | 2023-11-10 | 2025-05-15 | Purdue Research Foundation | Keto-amide-based fibroblast activation protein-targeted ligand linked to a pi3k inhibitor, compositions and methods of use |
| WO2025240868A1 (en) * | 2024-05-16 | 2025-11-20 | Purdue Research Foundation | Method of using chemically stable keto-amide fibroblast activation protein-targeted conjugates and compositions comprising same to treat fibrosis |
| CN119039397B (zh) * | 2024-10-17 | 2026-07-31 | 湖南中晟全肽生物科技股份有限公司 | 靶向成纤维细胞活化蛋白的多肽及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5599783B2 (ja) * | 2008-05-30 | 2014-10-01 | アムジエン・インコーポレーテツド | Ｐｉ３キナーゼの阻害薬 |
| TWI592411B (zh) | 2011-02-23 | 2017-07-21 | 英特爾立秦有限責任公司 | 激酶抑制劑之組合及其用途 |
| WO2013107820A1 (en) | 2012-01-17 | 2013-07-25 | Universiteit Antwerpen | Novel fap inhibitors |
| EP2866842A1 (en) * | 2012-06-29 | 2015-05-06 | GE Healthcare UK Limited | Imaging fibrosis |
| CN103788071A (zh) * | 2012-11-01 | 2014-05-14 | 中国人民解放军第二军医大学 | N-(5-(喹啉-6-基)吡啶-3-基)苯磺酰胺衍生物、制备方法及治疗用途 |
| IL325256A (en) * | 2014-06-13 | 2026-02-01 | Bach Biosciences Llc | FAP-activated medical materials and related uses |
| US10806806B2 (en) | 2016-06-23 | 2020-10-20 | Cornell University | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| JP7162592B2 (ja) * | 2016-12-14 | 2022-10-28 | パーデュー・リサーチ・ファウンデイション | 線維芽細胞活性化タンパク質（ｆａｐ）標的イメージングおよび治療 |
| KR102724812B1 (ko) | 2017-04-05 | 2024-11-01 | 코넬 유니버시티 | 영상화 및 항종양 치료요법에 유용한 조정 가능한 약동학을 갖는 삼작용성 작제물 |
| JP2021500373A (ja) | 2017-10-23 | 2021-01-07 | ザ・ジョンズ・ホプキンス・ユニバーシティ | 線維芽細胞活性化タンパク質α（ＦＡＰ−α）を標的とする撮像剤および放射線療法用薬剤 |
| CN112912731A (zh) | 2018-10-17 | 2021-06-04 | 普渡研究基金会 | 成纤维细胞活化蛋白(fap)靶向成像和纤维化治疗 |
| EP4132921A4 (en) * | 2020-04-09 | 2024-03-27 | Purdue Research Foundation | Pi3 kinase inhibitors and uses thereof |
-
2019
- 2019-10-15 CN CN201980068239.3A patent/CN112912731A/zh active Pending
- 2019-10-15 WO PCT/US2019/056257 patent/WO2020081522A1/en not_active Ceased
- 2019-10-15 US US17/285,717 patent/US11426472B2/en active Active
- 2019-10-15 EP EP19874435.1A patent/EP3867648A4/en active Pending
- 2019-10-15 AU AU2019360944A patent/AU2019360944B2/en not_active Ceased
- 2019-10-15 CA CA3116313A patent/CA3116313A1/en active Pending
- 2019-10-15 JP JP2021521113A patent/JP7161044B2/ja not_active Expired - Fee Related
-
2022
- 2022-06-29 US US17/809,810 patent/US11890357B2/en active Active
- 2022-08-30 AU AU2022224743A patent/AU2022224743A1/en not_active Abandoned
- 2022-10-13 JP JP2022164850A patent/JP2022191399A/ja not_active Withdrawn
-
2023
- 2023-12-22 US US18/395,366 patent/US20240165279A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7378449B2 (ja) | 軟骨ホーミングペプチド | |
| JP7161044B2 (ja) | 線維症における線維芽細胞活性化タンパク質（ｆａｐ）を標的とする撮像法および治療法 | |
| JP6666613B2 (ja) | 悪性腫瘍標的ペプチド | |
| WO2022017375A1 (zh) | 一种FAP-α特异性肿瘤诊断SPECT显像剂 | |
| JP2022527821A (ja) | Ｈｓｐ９０結合コンジュゲート及びその製剤 | |
| Menichetti et al. | MicroPET/CT imaging of αvβ3 integrin via a novel 68Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction | |
| WO2014176284A1 (en) | Selective drug delivery compositions and methods of use | |
| KR20180058822A (ko) | 전립선 특이적 막 항원（psma)의 18f-태그된 저해제 및 전립선암에 대한 조영제로서 이의 용도 | |
| KR102775891B1 (ko) | 신경 내분비 종양의 치료에서 이중 표적화를 위한 조성물 및 방법 | |
| JP2021130675A (ja) | 放射性核種錯体を調製するための方法およびキット | |
| JP2019196358A (ja) | 血清半減期を延長するための、調節可能リンカーを介した薬学的活性剤とトランスサイレチンリガンドのコンジュゲーション | |
| CN102212116B (zh) | 一种乙酰胆碱受体介导脑靶向多肽及其应用 | |
| JP6987840B2 (ja) | Ｉｄｏ１酵素イメージングのための放射性リガンド | |
| JP7376476B2 (ja) | Ｂｃｌ９ペプチドおよびそのバリアント | |
| WO2023030509A1 (zh) | 一种肽脲素衍生物、含其的药物组合物及其应用 | |
| CN116023438A (zh) | 一种cxcr4靶向多肽及其应用 | |
| US9956303B2 (en) | Anti-met therapy for previously diagnosed cancer patients | |
| JP5085824B2 (ja) | 低酸素の検出のために有用な化合物の製造 | |
| JP2024525687A5 (enExample) | ||
| WO2017120350A1 (en) | Peptide constructs combined with statin drugs and use thereof | |
| Dobrucki et al. | Regional hypoxia correlates with the uptake of a radiolabeled targeted marker of angiogenesis in rat model of myocardial hypertrophy and ischemic injury | |
| CN116063379A (zh) | EphA2靶向多肽及其应用 | |
| US20210284689A1 (en) | Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery | |
| CN101563108B (zh) | 基于放射性标记的肽的化合物及其用途 | |
| SK11392000A3 (sk) | Farmaceutické prostriedky odvodené od bibapcitidu na zobrazenie a liečbu trombov |